Relay Therapeutics, Inc. (RLAY) Tops Q4 EPS by 12c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q4 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
• Stifel: 'Meta Muse (And Consumer Agents Broadly) a L-T Positive For SHOP, TWLO'
• Bessent emerging as a frontrunner for U.S. President Donald Trump’s new “AI czar” position - Semafor